A phase Ib/II study of SHR-1701 (a bifunctional anti-PD-L1/TGF-RII agent) in combination with bevacizumab (BEV) in patients with advanced solid tumors
Bevacizumab;SHR-1701
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A phase Ib/II study of SHR-1701 (a bifunctional anti-PD-L1/TGF-RII agent) in combination with bevacizumab (BEV) in patients with advanced solid tumors ### Output: Bevacizumab;SHR-1701